Adderall®
Adderall®, the brand name for amphetamine-dextroamphetamine, was approved in 1996 for the treatment of attention deficit hyperactivity disorder (ADHD). The Federal Food and Drug Administration (FDA) released a report in February 2006, describing a potential link between Adderall® and the occurrence of heart attacks, high blood pressure and other cardiovascular complications that may result in sudden death. The FDA report cites 51 deaths that may have resulted from the use of Adderall® and Ritalin®, two drugs widely prescribed to treat ADHD.

Many reputable medical experts believe that Adderall® and Ritalin have been prescribed far too frequently as a treatment for behavioral problems in school-aged children. Because Adderall® is highly addictive and lends itself easily to abuse, these critics argue that the benefits of the drug are often outweighed by its risks and that, therefore, its prescription should be limited to very specific cases of ADHD.

If you or your children have been harmed call our Law Firm we can help.


Ritalin®
Ritalin®, also known as methylphenidate, has been widely prescribed to patients of all ages to combat an array of behavioral and attention deficit related disorders. A February 2006 FDA report indicates that Ritalin® may pose serious health risks including heart attack, stroke, high blood pressure, and other potentially fatal cardiovascular problems. The report finds that 51 deaths may be linked to the use of Ritalin® and Aderall®.

The FDA has been hesitant to suggest a definitive link between Ritalin® use and sudden death, but regulators have been warned to closely monitor the use of all ADHD drugs for potentially fatal side-effects.

If you or a loved one has taken Ritalin® and feel you may be at risk, call our Law Firm we can help.

We are committed to our clients. If you or a family member has suffered a loss - call us day or night at 1-888-513-6198 or locally at 210-922-2200